Skip to main content
Retour
Watch Compare

Coya Therapeutics, Inc.

Qualité des données : 100%
COYA
Nasdaq Manufacturing Chemicals
4,48 €
▲ 0,37 € (9,00%)
Cap. Boursière: 105,09 M
Prix
4,48 €
Cap. Boursière
105,09 M
Fourchette du Jour
4,14 € — 4,58 €
Fourchette 52 Semaines
3,71 € — 7,75 €
Volume
286 698
Ouverture 4,14 €
Moyenne 50J / 200J
4,60 €
2,56% below
Moyenne 50J / 200J
5,61 €
20,13% below

Quick Summary

Points Clés

Negative free cash flow of -10,74 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)123,57%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-76,36%
En dessous de la moyenne du secteur (-53,41%)
ROIC-62,16%
Net Margin-267,14%
Op. Margin-283,87%

Sécurité

Debt / Equity
N/A
Current Ratio8,73
Interest CoverageN/A

Valorisation

PE (TTM)
-4,95
En dessous de la moyenne du secteur (-1,48)
P/B Ratio3,85
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -5,0 -1,5
P/B 3,9 1,6
ROE % -76,4 -53,4
Net Margin % -267,1 -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 123,57% Revenue Growth (3Y) 15,06%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 7,95 M Net Income (TTM) -21,23 M
ROE -76,36% ROA -64,82%
Gross Margin N/A Operating Margin -283,87%
Net Margin -267,14% Free Cash Flow (TTM) -10,74 M
ROIC -62,16% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 8,73
Interest Coverage N/A Asset Turnover 0,24
Working Capital 28,36 M Tangible Book Value 27,28 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4,95 Forward P/E N/A
P/B Ratio 3,85 P/S Ratio 13,23
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -10,22%
Market Cap 105,09 M Enterprise Value 76,96 M
Per Share
EPS (Diluted TTM) -1,27 Revenue / Share 0,34
FCF / Share -0,46 OCF / Share -0,46
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 50,59%
SBC-Adj. FCF -14,70 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue 7,95 M 3,55 M 6,00 M —
Net Income -21,23 M -14,88 M -7,99 M -12,24 M
EPS (Diluted) -1,27 -0,98 -0,79 -4,73
Gross Profit — — — —
Operating Income -22,56 M -17,25 M -7,90 M -9,81 M
EBITDA — — — —
R&D Expenses — — — —
SG&A Expenses — — — —
D&A — — — —
Interest Expense — — — —
Income Tax 3 089,0 -720 287,0 723 852,0 —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 49,95 M 44,35 M 41,26 M 8,40 M
Total Liabilities 6,92 M 4,77 M 5,63 M 16,79 M
Shareholders' Equity 43,03 M 39,58 M 35,64 M -8,39 M
Total Debt — — — —
Cash & Equivalents 46,82 M 38,34 M 32,63 M 5,93 M
Current Assets 49,94 M 44,31 M 41,20 M 7,18 M
Current Liabilities 5,87 M 3,82 M 5,05 M 3,82 M